FDA Grants De Novo Authorization for AI-Powered Prostate Cancer Prognostic Software
The risk stratification tool is designed to predict long-term outcomes for patients with non-metastatic prostate cancer.
Read More
Search Results for: prostate cancer
Fellow Health Gains Approval to Offer At-Home Post-Vasectomy Test in New York
The company expands to nationwide availability with the addition of the New York State license.
Read More
Innovation Key to Reversing Decline in Routine Cancer Screenings
A new survey reveals declining cancer screening rates among U.S. adults, but shows strong interest in innovative screening methods.
Read More
Proscia’s AI Pathology Platform Sees 400% Growth in Daily Cases
Proscia is scaling its AI-powered Concentriq pathology platform, driving adoption through a variety of clinical and business benefits.
Read More
Saliva Analysis Could Reveal Disease Risk
A study shows that saliva contains genetic markers linked to systemic diseases for a non-invasive alternative to blood-based diagnostics.
Read More